Companies › SGMT

SAGIMET BIOSCIENCES INC (SGMT)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001400118 · EDGAR filings · Updated 2026-07-22

SAGIMET BIOSCIENCES INC (SGMT) has reported institutional ownership of 41.0%, with 87 institutional managers holding positions valued at $69.8M per the latest 13F reporting period.

Filings this week (3)

• 2026-07-22 — Insider transaction reported (Form 4)
• 2026-07-22 — Insider transaction reported (Form 4)
• 2026-07-22 — Insider transaction reported (Form 4)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-21 — Current report (8-K) filed
• 2026-07-20 — Notice of proposed sale filed (Form 144)
• 2026-06-15 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, SAGIMET BIOSCIENCES INC has 87 institutional holders and institutional ownership of 41.0%.

Insider activity

Insiders reported 13 transactions (0 buys, 8 sells) across 5 reporting insiders, with a net reported value of −$1.17M.

Related companies

CARIBOU BIOSCIENCES INC (CRBU) · SNDL INC (SNDL) · IMMUNIC (IMUX) · AC IMMUNE SA (ACIU) · LEONABIO INC (LONA) · Unicycive Therapeutics Inc (UNCY)